Literature DB >> 24429918

Neurocognitive therapeutic exercise improves pain and function in patients with shoulder impingement syndrome: a single-blind randomized controlled clinical trial.

E Marzetti1, A Rabini, G Piccinini, D B Piazzini, M C Vulpiani, M Vetrano, A Specchia, G Ferriero, C Bertolini, V M Saraceni.   

Abstract

BACKGROUND: Traditional rehabilitation improves pain and function in patients with shoulder impingement syndrome. Neurocognitive rehabilitation has shown to be highly effective after surgical reconstruction of the anterior cruciate ligament. However, its effects in patients with shoulder impingement syndrome have not yet been established. AIM: The aim of the study was to compare the effects of neurocognitive therapeutic exercise, based on proprioception and neuromuscular control, on pain and function in comparison to traditional therapeutic exercise in patients with shoulder impingement syndrome.
DESIGN: Single-blind randomized, non-inferiority clinical trial.
SETTING: Outpatient clinic of Geriatrics and Physiatrics, University Hospital. POPULATION: Forty-eight patients with shoulder impingement syndrome (Neer stage I) and pain lasting for at least three months.
METHODS: Participants were randomly allocated (1:1) to either neurocognitive therapeutic exercise or traditional therapeutic exercise. Both treatments were provided one-hour session, three times a week for five weeks. The primary outcome measure was the short form of the Disability of the Arm, Shoulder and Hand Questionnaire (Quick-DASH questionnaire) for the assessment of physical ability and symptoms of the upper extremity. SECONDARY OUTCOME MEASURES: Constant-Murley shoulder outcome score for the determination of range of motion, pain and strength; American Shoulder and Elbow Surgeons Society standardized shoulder assessment form for the evaluation of physical ability in daily-living tasks; a visual analogue scale for pain assessment at rest and during movements; Likert score for the estimation of participant satisfaction. ENDPOINTS: before treatment, end of treatment, 12 and 24 weeks after the completion of each intervention for all outcome measures, except for the Likert score that was evaluated only at the end of treatment. FOLLOW-UP: 24 weeks.
RESULTS: At the end of treatment and at follow-up, both treatment groups experienced improvements in all outcomes measures relative to baseline values, except for the visual analogue scale at rest that was unaffected by traditional therapeutic exercise. For all outcome measures, changes over time were greater in the neurocognitive therapeutic exercise group relative to the traditional therapeutic exercise group. The level of satisfaction with treatment was higher for participants in the neurocognitive therapeutic exercise group.
CONCLUSION: Neurocognitive rehabilitation is effective in reducing pain and improving function in patients with shoulder impingement syndrome, with benefits maintained for at least 24 weeks. CLINICAL REHABILITATION IMPACT: skills and function of the shoulder can greatly benefit from neurocognitive rehabilitation.

Entities:  

Mesh:

Year:  2014        PMID: 24429918

Source DB:  PubMed          Journal:  Eur J Phys Rehabil Med        ISSN: 1973-9087            Impact factor:   2.874


  12 in total

1.  SHORT-TERM EFFECTS OF INSTRUMENT-ASSISTED SOFT TISSUE MOBILIZATION ON PAIN FREE RANGE OF MOTION IN A WEIGHTLIFTER WITH SUBACROMIAL PAIN SYNDROME.

Authors:  Joseph Paul Coviello; Rumit Singh Kakar; Timothy James Reynolds
Journal:  Int J Sports Phys Ther       Date:  2017-02

Review 2.  Teres minor and quadrilateral space syndrome: A review.

Authors:  Nicholas Dalagiannis; Meaghan Tranovich; Nabil Ebraheim
Journal:  J Orthop       Date:  2020-01-21

Review 3.  Screening of the cervical spine in subacromial shoulder pain: A systematic review.

Authors:  Tom Walker; Emma Salt; Greg Lynch; Chris Littlewood
Journal:  Shoulder Elbow       Date:  2018-09-20

4.  A neurocognitive approach for recovering upper extremity movement following subacute stroke: a randomized controlled pilot study.

Authors:  Laia Sallés; Patricia Martín-Casas; Xavier Gironès; María José Durà; José Vicente Lafuente; Carlo Perfetti
Journal:  J Phys Ther Sci       Date:  2017-04-20

Review 5.  Specific or general exercise strategy for subacromial impingement syndrome-does it matter? A systematic literature review and meta analysis.

Authors:  Alison R Shire; Thor A B Stæhr; Jesper B Overby; Mathias Bastholm Dahl; Julie Sandell Jacobsen; David Høyrup Christiansen
Journal:  BMC Musculoskelet Disord       Date:  2017-04-17       Impact factor: 2.362

6.  Development and validation of a shoulder-specific body-perception questionnaire in people with persistent shoulder pain.

Authors:  Tomohiko Nishigami; Akihisa Watanabe; Toshiki Maitani; Hayato Shigetoh; Akira Mibu; Benedict Martin Wand; Mark J Catley; Tasha R Stanton; G Lorimer Moseley
Journal:  BMC Musculoskelet Disord       Date:  2021-01-21       Impact factor: 2.362

7.  Rotator cuff disorders: a survey of current (2016) UK physiotherapy practice.

Authors:  Julie Bury; Chris Littlewood
Journal:  Shoulder Elbow       Date:  2017-07-11

8.  Pain Management through Neurocognitive Therapeutic Exercises in Hypermobile Ehlers-Danlos Syndrome Patients with Chronic Low Back Pain.

Authors:  Claudia Celletti; Teresa Paolucci; Loredana Maggi; Giordana Volpi; Mariangela Billi; Roberta Mollica; Filippo Camerota
Journal:  Biomed Res Int       Date:  2021-06-01       Impact factor: 3.411

9.  Usefulness of rehabilitation in patients with rotator cuff calcific tendinopathy after ultrasound-guided percutaneous treatment.

Authors:  Michele Abate; Cosima Schiavone; Vincenzo Salini
Journal:  Med Princ Pract       Date:  2014-09-06       Impact factor: 1.927

10.  Content reporting of exercise interventions in rotator cuff disease trials: results from application of the Consensus on Exercise Reporting Template (CERT).

Authors:  Daniel H Major; Yngve Røe; Margreth Grotle; Rebecca L Jessup; Caitlin Farmer; Milada Cvancarova Småstuen; Rachelle Buchbinder
Journal:  BMJ Open Sport Exerc Med       Date:  2019-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.